首页> 外国专利> Biomarker for diagnosing or prognosis predicting of cholangiocarcinoma and use thereof

Biomarker for diagnosing or prognosis predicting of cholangiocarcinoma and use thereof

机译:用于诊断或预测胆管癌的生物标志物及其用途

摘要

The present invention relates to a biomarker for diagnosis or prognosis of biliary tract cancer and its use, wherein TGFBI mRNA is highly expressed in biliary tract cancer tissue, TGFBI protein is specifically expressed in biliary tract cancer cell line, It was confirmed that the soluble TGFBI protein content was high and the prognosis of the patients with biliary tract cancer with high expression of the TGFBI gene was significantly poor through analysis of the gene database including prognostic information. Therefore, the TGFBI may be usefully used as a biomarker for diagnosing or prognosticting biliary tract cancer.
机译:本发明涉及用于诊断或预后胆道癌的生物标志物及其用途,其中TGFBI mRNA在胆道癌组织中高表达,TGFBI蛋白在胆道癌细胞系中特异性表达,证实了可溶性TGFBI通过分析包括预后信息在内的基因数据库,TGFBI基因高表达的胆道癌患者蛋白水平高,预后很差。因此,TGFBI可以有效地用作诊断或预后胆道癌的生物标志物。

著录项

  • 公开/公告号KR102082344B1

    专利类型

  • 公开/公告日2020-02-27

    原文格式PDF

  • 申请/专利权人 조성은;

    申请/专利号KR20180071351

  • 发明设计人 조성은;이중회;이광남;황명옥;

    申请日2018-06-21

  • 分类号C12Q1/6886;G01N33/574;

  • 国家 KR

  • 入库时间 2022-08-21 11:05:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号